Upgrade to SI Premium - Free Trial

Verrica Pharmaceuticals Inc. (VRCA)

3.63 +0.16 (4.61%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences September 30, 2026 8:00 AM - StreetInsider Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences September 10, 2026 8:05 AM - StreetInsider Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 8, 2026 8:00 AM - StreetInsider Verrica completes enrollment in YCANTH wart trial, data due Q1 2027 August 27, 2026 8:00 AM - StreetInsider Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027 August 27, 2026 8:00 AM - StreetInsider Lake Street Starts Verrica Pharmaceuticals (VRCA) at Buy August 27, 2026 7:56 AM - StreetInsider Form 4 Verrica Pharmaceuticals For: Aug 17 Filed by: Zawitz David August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 14 Filed by: Rieger Jayson August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 18 Filed by: Kirby John J. August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 17 Filed by: Rosenberg Noah L. August 18, 2026 5:00 PM - SEC Filing Verrica Pharmaceuticals Inc. (VRCA) Misses Q2 EPS by 8c August 6, 2026 4:46 PM - StreetInsider Form 10-Q Verrica Pharmaceuticals For: Jun 30 August 6, 2026 4:43 PM - SEC Filing Form 8-K Verrica Pharmaceuticals For: Aug 06 August 6, 2026 4:40 PM - SEC Filing Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results August 6, 2026 4:05 PM - StreetInsider Verrica Pharmaceuticals closes $27.5M credit facility with chairman August 6, 2026 4:01 PM - StreetInsider Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital  August 6, 2026 4:01 PM - StreetInsider Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 July 30, 2026 8:00 AM - StreetInsider Full Article List